Review
Open access
Jul 2026
Cellular Immunotherapy for Acute Myeloid Leukemia: From Bench to Bedside
It is concluded that while cellular immunotherapies represent a transformative frontier in AML treatment, their broad application is currently constrained by target antigen heterogeneity, a complex tumor microenvironment, and significant toxicities.
Yu Wang, Jia-Ying Wu, Xiao-Bing Huang et al.
· Immunotherapy Advances · 0 citations